CClinicalTrials.gg
CompletedNCT02082275Updated Jan 8, 2016

OB Nest; Redefining Continuity of Care for Expectant Mothers

An interventional study of OB Nest in Pregnancy, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-01-08.

Sponsored by Mayo Clinic · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The study defines a new model of prenatal care called OB Nest which will be compared to the traditional model of prenatal care. OB nest is intended to create an experience for patients that feels more connected and patient-centered, allowing the patient to visit the clinic less frequently while offering increased communication with the OB nurses and providers through new tools provided to the patient. The goal of the project is to promote patient-centered care through a new prenatal care program based on constant and direct support from a nursing team, meeting the on-demand needs of expecting mothers as they rise, and as thus, redesigning the need and timing of on-site appointment with providers. Pregnant women randomized to the OB Nest cohort will see the number of pre-planned visits with their providers decreased and replaced with more direct and constant support and interaction with an assigned nursing team.

Read the detailed description

OB Nest is a model designed to promote increased patient-centered care during pregnancy. OB Nest care will allow for more flexibility, decrease interruptions to your productivity, while continuing to maintain safety for you and your infant. This model of care is anticipated to allow you more access to your health care team during your pregnancy.

This study will compare OB Nest, a new model of prenatal care, to the existing traditional model of prenatal care. The plan is to have about 300 low-risk mothers take part in this study. Eligible patients will be randomized to one of two groups; The Traditional Prenatal care Group or the OB Nest Group. Mothers will have an equal chance of being assigned to the OB Nest group. Mothers randomized to the OB Nest intervention will be assigned to a nursing care team comprised of one to three nurses and see their initial eleven planned appointments with their provider reduced to six. Mothers will still be able to request additional in-office visits with their provider and/or the provider require additional in-office visits to monitor mother and infants safety/care.

02

Conditions studied

  • Pregnancy

Keywords

  • Prenatal Care
  • Obstetrics
03

In context

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18+ years of age
  • Documented gestational age less than 13 weeks.
  • Pregnancy documented as low risk (See high risk exclusion criteria below)
  • Able to read and understand English
  • Able to provide informed consent (i.e. no impairments or barriers)

Exclusion criteria

Exclusion Criteria:

Clinical judgment that determines that the pregnancy is at high risk for complications.

Any of the following high risk factors would disqualify the mother for the study:

  • Severe hypertension (>160/110)
  • Possible ectopic
  • Congenital adrenal hypertension
  • Prior PE/DVT/stroke
  • Anticoagulation during prior pregnancy (e.g. antiphospholipid antibody syndrome)
  • Prosthetic heart valve (non-bio)
  • Pulmonary hypertension
  • Mothers currently taking Immunosuppressants, Prednisone > 10mg per day, antipsychotic (e.g. lithium, Haldol, Zyprexa), chemotherapy
  • Recurrent pregnancy loss (>2 losses)
  • Current maternal malignancy
  • Prior myocardial infarction/cardiomyopathy
  • Bio-prosthetic heart valves
  • Marfan syndrome
  • Active liver disease (e.g. hepatitis)
  • Congenital heart disease
  • Coagulopathies including thrombophilias and bleeding disorders.
  • Pre-existing diabetes
  • Genetic disease/CF testing/anomalies in prior child
  • Incompetent cervix (prior cerclage)
  • Triplets or quads diagnosed by REI or ultrasound.
  • Isoimmunization (Rh, Kell, etc.)
  • History of transplant or currently on Dialysis
  • Recurrent pregnancy loss (antiphospholipid antibody syndrome or collagen vascular disease)
  • Chronic hypertension
  • Prior 2nd or 3rd trimester loss
  • HIV
  • Inflammatory bowel disease
  • Asthma and currently on steroid to control disease
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (actual)

Study arms

  • Experimental
    OB Nest

    OB Nest is designed to reduce the number of pre-planned visits with their OB provider and replace the in-clinic visits with a direct and constant support from an assigned nursing team. OB Nest will empower moms-to-be to take ownership of their prenatal care by providing a wealth of resources.

    Other: OB Nest

  • No intervention
    Traditional Prenatal care

    Traditional prenatal visits in clinic with OB providers.

Interventions

  • OtherOB Nest

    * Reduction in the number of clinic office visits * Assignment to a specific nursing care team * Support and direct interaction available through tools which supports mom's empowerment to address her concerns, care for herself and connect with OB as necessary between clinic visits. * Empower and enable mothers to complete at home measurements for fetal heart rate, weight, and blood pressures. * Augmentation of in-person visits between care providers and patients with video conversations. * Maternal outcomes will be monitored through surveys and questionnaires.

06

What researchers measure

Primary outcomes

  1. Expectant mothers satisfaction of prenatal care

    At 36 weeks the expectant mother will complete a survey that assessed their satisfaction of the prenatal care received using a validated scale.

    Time frame: 36 weeks

07

Study locations

1 site
  • Mayo Clinic in Rochester
    Rochester, Minnesota 55905, United States
08

References and documents

Publications

  • Theiler RN, Butler-Tobah Y, Hathcock MA, Famuyide A. OB Nest randomized controlled trial: a cost comparison of reduced visit compared to traditional prenatal care. BMC Pregnancy Childbirth. 2021 Jan 21;21(1):71. doi: 10.1186/s12884-021-03557-3. PubMed 33478433 ↗
  • Butler Tobah YS, LeBlanc A, Branda ME, Inselman JW, Morris MA, Ridgeway JL, Finnie DM, Theiler R, Torbenson VE, Brodrick EM, Meylor de Mooij M, Gostout B, Famuyide A. Randomized comparison of a reduced-visit prenatal care model enhanced with remote monitoring. Am J Obstet Gynecol. 2019 Dec;221(6):638.e1-638.e8. doi: 10.1016/j.ajog.2019.06.034. Epub 2019 Jun 19. PubMed 31228414 ↗
  • Ridgeway JL, LeBlanc A, Branda M, Harms RW, Morris MA, Nesbitt K, Gostout BS, Barkey LM, Sobolewski SM, Brodrick E, Inselman J, Baron A, Sivly A, Baker M, Finnie D, Chaudhry R, Famuyide AO. Implementation of a new prenatal care model to reduce office visits and increase connectivity and continuity of care: protocol for a mixed-methods study. BMC Pregnancy Childbirth. 2015 Dec 2;15:323. doi: 10.1186/s12884-015-0762-2. PubMed 26631000 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02082275
Lead sponsor
Mayo Clinic
Responsible party
Abimbola Famuyide (Associate Professor of Obstetrics-Gynecology, Mayo Clinic) — Principal investigator
First posted
Mar 10, 2014
Start date
Feb 2014
Primary completion
Oct 2015
Completion
Nov 2015
Last update
Jan 8, 2016

Study contacts

Abimbola Famuyide, MBBS
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion